ClinicalTrials.Veeva

Menu
R

Richmond Pharmacology | London, United Kingdom

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

NTLA-2001
TETA 4HCL
Cuprior®
Trientine Base
Noribogaine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials
Locations recently updated

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

To evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM.

Enrolling
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Drug: Placebo
Biological: NTLA-2001
Status recently updated

This trial will be a randomised, double-blind, sequential-group, multiple-dose, placebo-controlled, dose escalation trial to characterise the pharmac...

Not yet enrolling
Enrolling
Pharmacokinetics
Drug: Noribogaine

Trial sponsors

E
I
O
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems